← Leaderboards
Roel Gw Verhaak
Yale University
$8,014,607
Attributed
$11,803,567
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,732,738 · 10
By mechanism
U2C$12,620,849 · 2
R01$5,800,957 · 3
R33$1,377,810 · 1
OT2$1,172,048 · 1
R21$997,980 · 2
P01$763,094 · 1
Top collaborators
- Elizabeth B. Claus8 shared
- Bethany Matthews Kwan8 shared
- Erik Sulman4 shared
- Vassiliki A Boussiotis3 shared
- Alain Charest3 shared
- Chia-Lin Wei1 shared
Most similar at Yale University
Same institution · by research overlap
- Markus Gabriel Manz$1,663,796
- Richard A Flavell$31,785,615
- Elizabeth B. Claus$21,096,464
- Peter M Glazer$37,467,142
- Graeme F Mason$12,986,867
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenomicsEvolutionTumorResistanceMalignant NeoplasmsGenomeAffectThe Cancer Genome AtlasRecurrenceNeoplastic CellBaseInsightData SetBiological ModelsSamplingMutationCharacteristicsGlioblastomaInnovationTechnologyInternationalCancer TypeHeterogeneity
Grant awards (35)
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)$1,999,257
U2C · FY2025 · CA
Genome Characterization Unit$793,006
U2C · FY2025 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.$648,380
R01 · FY2025 · CA
eDyNAmiC - YALE$318,544
OT2 · FY2025 · CA · contact PI
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)$771,769
U2C · FY2024 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.$618,825
R01 · FY2024 · CA
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma$440,786
R01 · FY2024 · CA · contact PI
Genome Characterization Unit$425,869
U2C · FY2024 · CA
eDyNAmiC - JACKSONLAB$241,247
OT2 · FY2024 · CA · contact PI
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)$1,447,257
U2C · FY2023 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.$672,634
R01 · FY2023 · CA
Genome Characterization Unit$472,803
U2C · FY2023 · CA
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma$302,433
R01 · FY2023 · CA · contact PI
eDyNAmiC - JACKSONLAB$293,654
OT2 · FY2023 · CA · contact PI
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma$210,638
R01 · FY2023 · CA · contact PI
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)$3,587,938
U2C · FY2022 · CA
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma$513,071
R01 · FY2022 · CA · contact PI
eDyNAmiC - JACKSONLAB$318,603
OT2 · FY2022 · CA · contact PI
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)$3,122,950
U2C · FY2021 · CA
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma$518,051
R01 · FY2021 · CA · contact PI
Characterization of extrachromosomal DNAs in tumors through computational analysis of single-cell and bulk sequencing data$406,138
R21 · FY2021 · CA · contact PI
Characterization of extrachromosomal DNAs in tumors through computational analysis of single-cell and bulk sequencing data$72,092
R21 · FY2021 · CA · contact PI
Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer$1,377,810
R33 · FY2020 · CA
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma$518,051
R01 · FY2020 · CA · contact PI
Modeling Tumor Evolution in Glioma$189,000
R21 · FY2020 · NS · contact PI
Modeling Tumor Evolution in Glioma$330,750
R21 · FY2019 · NS · contact PI
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma$362,088
R01 · FY2017 · CA · contact PI
Bioinformatics Core$153,938
P01 · FY2017 · CA · contact PI
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma$332,000
R01 · FY2016 · CA · contact PI
Bioinformatics Core$154,329
P01 · FY2016 · CA · contact PI
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto$332,000
R01 · FY2015 · CA · contact PI
Bioinformatics Core$152,821
P01 · FY2015 · CA · contact PI
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto$332,000
R01 · FY2014 · CA · contact PI
Bioinformatics Core$147,529
P01 · FY2014 · CA · contact PI
Bioinformatics Core$154,477
P01 · FY2013 · CA · contact PI